Mesothelin as a potential therapeutic target in human cholangiocarcinoma.

Yu, Liping

Mesothelin as a potential therapeutic target in human cholangiocarcinoma. [electronic resource] - Journal of Cancer Oct 2010 - 141-9 p. digital

Publication Type: Journal Article

ISSN: 1837-9664

Standard No.: 10.7150/jca.1.141 doi

Mesothelin as a potential therapeutic target in human cholangiocarcinoma.

APA

Yu L., Feng M., Kim H., Phung Y., Kleiner D. E., Gores G. J., Qian M., Wang X. W. & Ho M. (20110714). Mesothelin as a potential therapeutic target in human cholangiocarcinoma. : Journal of Cancer.

Chicago

Yu Liping, Feng Mingqian, Kim Heungnam, Phung Yen, Kleiner David E, Gores Gregory J, Qian Min, Wang Xin Wei and Ho Mitchell. 20110714. Mesothelin as a potential therapeutic target in human cholangiocarcinoma. : Journal of Cancer.

Harvard

Yu L., Feng M., Kim H., Phung Y., Kleiner D. E., Gores G. J., Qian M., Wang X. W. and Ho M. (20110714). Mesothelin as a potential therapeutic target in human cholangiocarcinoma. : Journal of Cancer.

MLA

Yu Liping, Feng Mingqian, Kim Heungnam, Phung Yen, Kleiner David E, Gores Gregory J, Qian Min, Wang Xin Wei and Ho Mitchell. Mesothelin as a potential therapeutic target in human cholangiocarcinoma. : Journal of Cancer. 20110714.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC